A Robust Control Group Identification Approach for Reference Intervals of Thyroid Biomarkers: The Case of Jordan
Medical Sciences · 30.06.2026 · 14 (3) · 362
DOI: 10.3390/medsci14030362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 30.06.2026. Verfasst von Areej Mohammed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial Engineering, American University of Sharjah, Sharjah P.O. Box 26666, United Arab Emirates. Hauptthemen laut MEDLINE: Biomarkers, Thyroid Gland, Thyroid Diseases. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Office, Jordanian Ministry of Higher Education, American University of Sharjah.
Abstract (Originalsprache)
Purpose
This study introduces a robust approach for establishing reference intervals (RIs) for thyroid biomarkers in the Jordanian population by incorporating symptoms-based criteria into the control group selection. This method enhances the traditional inclusion–exclusion criteria by adding a symptom layer. Five thyroid biomarkers were analyzed: thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), thyroid receptor antibodies (TRAbs), and antithyroid peroxidase antibodies (TPOAb). The study also investigated the prevalence of thyroid disorders using the established population-specific RIs. Patients and Methods: Samples from 6782 participants across different regions were collected between June 2016 and May 2017. The Kruskal–Wallis and the Mann–Whitney tests identified the best partitioning based on age–gender significant differences, and 2.5th–97.5th percentiles were used to establish the RIs.
Results
The TSH, FT4, and FT3 differed significantly among males and females, while no significant differences were found among different age groups. The RIs for males were as follows: TSH, 0.50–4.18 mIU/L; FT4, 12.00–21.16 pmol/L; and FT3, 2.28–4.17 pmol/L, while the corresponding RIs for females were as follows: TSH, 0.57–4.61 mIU/L; FT4, 12.02–24.69 pmol/L; and FT3, 2.53–3.71 pmol/L. TRAbs and TPOAb RIs were 0.3–1.89 IU/L and 0.83–23.87 IU/mL, respectively. The prevalence of overt hypothyroidism was 10.63%, subclinical hypothyroidism was 3.53%, overt hyperthyroidism was 0.66%, and subclinical hyperthyroidism was 1.52%.
Conclusions
This study emphasizes the role of population-specific RIs in minimizing diagnostic errors. The addition of symptom criteria improved control group identification and RI accuracy. These findings improve the diagnosis of thyroid disorders in Jordan and suggest a reproducible framework for worldwide application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Industrial Engineering, American University of Sharjah, Sharjah P.O. Box 26666, United Arab Emirates.
- Advanced Biosciences and Bioengineering Research Center, American University of Sharjah, Sharjah P.O. Box 26666, United Arab Emirates.
- Industrial Engineering Department, Jordan University of Science and Technology, Irbid P.O. Box 22110, Jordan.
- Department of Family and Community Medicine, School of Medicine, University of Jordan, Amman P.O. Box 11942, Jordan.
ORCID-Profile: Hussam Alshraideh, Abdulrahim Shamayleh
Förderung
- National Research Office, Jordanian Ministry of Higher Education
- American University of Sharjah
Zitieren
APA
Mohammed, A., Alshraideh, H., Abu-Helalah, M., & Shamayleh, A. (2026). A Robust Control Group Identification Approach for Reference Intervals of Thyroid Biomarkers: The Case of Jordan. Medical Sciences, 14(3), 362. https://doi.org/10.3390/medsci14030362
Vancouver
Mohammed A, Alshraideh H, Abu-Helalah M, Shamayleh A. A Robust Control Group Identification Approach for Reference Intervals of Thyroid Biomarkers: The Case of Jordan. Medical Sciences. 2026;14(3):362. doi:10.3390/medsci14030362
BibTeX
@article{Mohammed2026,
author = {Mohammed, Areej and Alshraideh, Hussam and Abu-Helalah, Munir and Shamayleh, Abdulrahim},
title = {A Robust Control Group Identification Approach for Reference Intervals of Thyroid Biomarkers: The Case of Jordan},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {3},
pages = {362},
doi = {10.3390/medsci14030362}
}
EUVIMED